Issue Date: October 24, 2016
Engineered plants produce malaria drug efficiently
Artemisinin, the primary component of standard combination therapies for malaria, is still relatively expensive and in short supply in some developing countries where the disease is endemic. Researchers are now trying to make the drug more accessible by engineering tobacco plants in two different ways to produce it with better efficiency. Extracting and purifying artemisinin from its natural plant source is expensive, and the plant, sweet wormwood, does not grow well in climates where malaria . . .
To view the rest of this content, please log in with your ACS ID.
- Chemical & Engineering News
- ISSN 0009-2347
- Copyright © American Chemical Society